BenAI Engine is the foundation of our end-to-end drug discovery offering

It uses machine learning to unlock the power of the vast and expanding biomedical data landscape to generate new insights into the underlying causes of disease.

Benevolent_Platform_2022_Data_Foundations_Data Sources.svg


Generating a 360° view of disease biology

Massive quantities of biomedical data are generated daily, yet scientists currently only use a fraction of the information available to understand the causes of diseases and propose new treatments. 

We provide scientists with a holistic view of disease biology by integrating as much data as possible across domains and diverse data types, including ’omics, molecules, experimental data, literature, pathology and biological systems. By bringing together these disparate, complex data sources, we break down silos across therapeutic areas to connect shared mechanisms across diseases.


Uncovering novel insights using domain specific AI models

We have developed, hand-in-hand with scientists, domain specific AI models that generate proprietary insights backed up by scientific evidence across the entire drug discovery and development process. These AI models are the foundation of our End-to-End drug discovery offering.


Turning data into knowledge

Our automated, custom-engineered processing pipelines make this disparate data accessible and useful for scientific enquiry. Machine learning models extract biomedical entities, such as genes, diseases, drugs, processes and cell types, and infer relationships that capture how these entities interact in a human system. 

These relationships form a network of contextualised scientific facts – providing a proprietary integrated view of biomedical data that supports discovery and decision making.